<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/8486</identifier>
				<datestamp>2022-10-20T00:04:17Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">An evaluation of arrival metaphylaxis with enrofloxacin compared to tulathromycin in feedlot cattle at high risk of developing bovine respiratory disease in Mexico</dc:title>
	<dc:creator xml:lang="en">Burciaga-Robles, Luis O.</dc:creator>
	<dc:creator xml:lang="en">McMullen, Christopher</dc:creator>
	<dc:creator xml:lang="en">Bras, Ana</dc:creator>
	<dc:creator xml:lang="en">Guerra-Maupome, Mariana</dc:creator>
	<dc:creator xml:lang="en">Nava-Gaspar, Rodolof A.</dc:creator>
	<dc:creator xml:lang="en">Rademacher, Ryan D.</dc:creator>
	<dc:creator xml:lang="en">Hannon, Sherry J.</dc:creator>
	<dc:creator xml:lang="en">Mercado-Talamantes, Victor E.</dc:creator>
	<dc:creator xml:lang="en">Booker, Calvin W.</dc:creator>
	<dc:subject xml:lang="en">Baytril Max formula L.A.</dc:subject>
	<dc:subject xml:lang="en">Draxxin</dc:subject>
	<dc:subject xml:lang="en">shipping fever</dc:subject>
	<dc:subject xml:lang="en">flouroquinolone</dc:subject>
	<dc:subject xml:lang="en">beef</dc:subject>
	<dc:description xml:lang="en">&amp;nbsp;
In this large-pen commercial field trial, mixed beef-breed bulls and heifers were randomly allocated at feedlot arrival to 1 of 2 experimental groups: ENRO or TULA. Animals in the ENRO group (10 multi-pen lots; 2037 animals) received a subcutaneous injection of enrofloxacin at a dosage of 3.4 mg/lb (7.5 mg/kg) body weight once at allocation. Animals in the TULA group (10 multi-pen lots; 2036 animals) received a subcutaneous in­jection of tulathromycin at a dosage of 1.1 mg/lb (2.5 mg/kg) body weight once at allocation. Study animals were housed by experimental group in commercial feedlot pens and fol­lowed from allocation until slaughter. There were no statisti­cal differences detected in any of the animal health or feedlot performance outcome variables between the experimental groups at the P &amp;lt; 0.050 level. Given the lack of detectable sta­tistical differences in animal health and feedlot performance outcome variables in the current study, the relative cost effec­tiveness of metaphylaxis programs utilizing enrofloxacin or tulathromycin in mixed beef-breed bulls and heifers at high risk of developing bovine respiratory disease should be depen­dent on the relative cost of each program, as well as any intan­gible attributes such as syringability, storage requirements, potential for antimicrobial resistance, etc.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2022-10-19</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8486</dc:identifier>
	<dc:identifier>10.21423/bovine-vol56no1p53-59</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 56 No. 1 (2022); 53-59</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8486/8287</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2022 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
